Study of Colchicine to Reduce Inflammatory Organ Injury in Patients Aged 50 to 80 Undergoing Cardiac Surgery with Cardiopulmonary Bypass
Led by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Updated on 2025-11-17
768
Participants Needed
1
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the effects of colchicine on inflammation and organ injury in patients undergoing cardiac surgery with cardiopulmonary bypass. This is a multicenter, randomized, controlled, double-blind clinical trial including 768 patients aged 50 to 80 scheduled for elective cardiac surgery. The goal is to evaluate how colchicine influences inflammatory factors, organ damage in the heart, lungs, liver, and kidneys, and to monitor for side effects like leukopenia and thrombocytopenia.
Participants are randomly assigned to either an experimental group or a control group. The experimental group takes 0.5 mg of colchicine tablets orally for three days before surgery and then continues to take 0.5 mg every other day for ten days after tracheal extubation. The control group receives placebo tablets on the same schedule. Both groups continue their standard treatments during this period.
Throughout the study, researchers collect demographic and clinical data and monitor various indicators including inflammatory markers, oxygenation levels, white blood cell counts, liver and kidney function, lung injury scores, and cardiac injury markers. They also track mechanical ventilation time, ICU stay length, gastrointestinal reactions, and mortality rates at 30 and 90 days post-surgery. The primary outcomes focus on postoperative complications such as atrial fibrillation, myocardial injury, acute respiratory distress syndrome, and postoperative pulmonary syndrome within ten days after surgery.
CONDITIONS
Brief Title
Effect of Colchicine on Perioperative Anti-inflammatory Organ Injury in Cardiac Surgery
Research Team
T
Tuo Pan, MD
D
Dongjin Wang, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients diagnosed with infectious diseases, inflammatory immune diseases, or tumor
Patients who have received immunosuppressive or anti-inflammatory treatment
Patients allergic or intolerant to colchicine
Breastfeeding or pregnant women
Other situations deemed inappropriate for participation by the investigator
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Approximately 2 weeks covering 3 days before surgery and 10 days after extubation
Participants take 0.5mg of colchicine or placebo tablets orally for 3 days before surgery and continue to take 0.5mg every other day for 10 days after tracheal extubation while undergoing their scheduled cardiac surgery.
1 baseline visit, surgery day visit, and multiple visits during the 10 days post-extubation
Follow-up
Duration - Up to 90 days post-surgery
Participants are monitored for inflammatory markers, organ injury, adverse events, and survival outcomes after treatment ends.
Visits on postoperative days 1, 3, 5, 7, 10, 14, 28, 30, and 90
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Implementation of the Ask Questions About Clinical Trials ASQ-CT Brochure to Improve Communication and Invitations for Clinical Trials
Study of Body Composition, Pain, and Inflammation in Adults With Spinal Cord Injury
Comparing Responses to High Fat and Moderate Fat Meals
Boston Scientific Rhythm Management Registry
Observational Post-Market Surveillance of Cardiac Devices
Collecting Long-Term Safety and Performance Data
Comparing Cardiac Clearance and Orthopedic Hip Frailty Score in Older Adults with Hip Fractures
Heart Function and Cirrhotic Cardiomyopathy in Adults with Metabolic Dysfunction-Associated Fatty Liver Disease
Cardio-Oncology Registry Study to Detect Early Heart Problems in Cancer Patients
Evaluating Brain and Inflammatory Effects of a 12-Week Exercise Program Added to Standard Treatment in Major Depressive Disorder
Observational Study on Memory CD8 T Cells and Their Link to Sepsis Severity and Mortality in ICU Patients
Study of Daoist Zhanzhuang Meditations Effects on Stress, Immunity, and Well-Being in Young Adults Ages 18 to 25
AI-Based Detection of Heart Electrical Disorders and Risk of Dangerous Ventricular Arrhythmias Using ECG Analysis
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Anti-inflammatory effect of colchicine on organ damage during the perioperative period of cardiac surgery: a study protocol for a multicentre, randomised, double-blind, placebo-controlled clinical trial.